Safety and Efficacy of the Novel OmniaSecure Defibrillation Lead Through Long-Term Follow-Up: Final Results From the LEADR Trial
The final results of the LEADR trial demonstrated 3-year term safety, efficacy, and reliability of the OmniaSecure lead, emphasizing the potential utility of this lead in a wide variety of patients.
Authors
- Paolo De Filippo (ORCID: https://orcid.org/0000-0002-1144-5000)
- Pamela Kay Mason (ORCID: https://orcid.org/0000-0002-4276-2391)
- Travis D. Richardson (ORCID: https://orcid.org/0000-0002-9772-0308)
- Prashanthan Sanders (ORCID: https://orcid.org/0000-0003-3803-8429)
- George H. Crossley (ORCID: https://orcid.org/0000-0003-0096-8401)
- Maully J. Shah (ORCID: https://orcid.org/0000-0002-4743-6915)
- Baerbel Maus (ORCID: https://orcid.org/0000-0002-3058-6183)
- Surinder Kaur Khelae (ORCID: https://orcid.org/0000-0002-7865-7323)
- Tessa Geelen (ORCID: https://orcid.org/0009-0006-5254-8678)
- John S. Zakaib (ORCID: https://orcid.org/0009-0001-3754-6555)
- François Philippon (ORCID: https://orcid.org/0000-0002-2012-0486)
- Bert Hansky (ORCID: https://orcid.org/0009-0002-4592-7734)
- Katherin Arias
Institutions
- Royal Adelaide Hospital (AU)
- Children's Hospital of Philadelphia (US)
- Bakken Museum (US)
- Medtronic (Ireland) (IE)
- Medtronic (United States) (US)
- Ospedale Papa Giovanni XXIII (IT)
- Medtronic (Netherlands) (NL)
- Klinikum Bielefeld (DE)
- Minneapolis Heart Institute Foundation (US)
- University of Virginia Medical Center (US)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- National Heart Institute (MY)
- Université Laval (CA)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Circulation Arrhythmia and Electrophysiology
- Published
- 2025-11-12
- DOI
- https://doi.org/10.1161/circep.125.014424
- Citations
- 2
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 2.78